Thursday, October 29, 2026

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.

Korean Opposition Party’s U.S. Visit: Key Diplomatic Strategies for 2026

The People Power Party's delegation, led by Jang Dong-hyuk, is meeting U.S. officials to discuss Middle East issues and U.S.-South Korea relations.

MADNESS Confirmed: North Korea Unveils Insane ICBM Fleet Ready To NUKE Washington D.C. NOW

North Korea enhances its nuclear strategy, showcasing advanced weaponry at a military parade, signaling a shift in its defense posture.

Seo Yoon Choi

2026’s Game-Changer: Canine Influenza Vaccine “CaniFlu-max” Now Approved for Subcutaneous Injection

A new subcutaneous influenza vaccine for dogs, CaniFlu-max, enhances treatment flexibility and has a strong safety profile.

2026’s New Radiation-Resistant RaonMedix Gear: A Game Changer for Veterinarians?

S&C Company introduces lead-free radiation protective gear for vets, addressing safety concerns amidst rising digital imaging use.

How South Korea is Pioneering Pet Healthcare: Insights from the New Pet Disease Research Lab

South Korea's new Pet Disease Research Laboratory shifts focus to pet health, emphasizing welfare and safety in public health initiatives.

Why Simparica Trio is the Top Choice for Pet Owners: 100% Heartworm Prevention Explained

Zoetis launches Simparica Trio in South Korea, a monthly parasite chew for pets, combining multiple treatments for effective protection.

Xenovax PCM4: The Next-Gen Vaccine Transforming Pig Farming in Asia – Find Out How!

CARESIDE's swine vaccine technology certified as New Excellent Technology, enhancing protection and reducing farmer labor demands.

Top News

- Our Sponsors Ad -

Follow us